AAAAAA

   
Results: 1-8 |
Results: 8

Authors: SAKEMI T YOSHIYUKI T IKEDA Y SUZUKI N NAGASAWA K
Citation: T. Sakemi et al., END-STAGE RENAL-FAILURE DUE TO CRESCENTIC GLOMERULONEPHRITIS IN A PATIENT WITH BEHCETS-SYNDROME - REVIEW OF THE LITERATURE, American journal of nephrology, 18(4), 1998, pp. 321-324

Authors: MATSUKURA N ONDA M KATO S HASEGAWA H YOSHIYUKI T SHIRAKAWA T TAKITA M AKIYA Y IKEDA K OKAWA K TOKUNAGA A YAMAHATSU J WEN M YAMADA N
Citation: N. Matsukura et al., REVERSIBILITY OF INTESTINAL METAPLASIA IN THE STOMACH AFTER HELICOBACTER-PYLORI ERADICATION, Gastroenterology, 114(4), 1998, pp. 901-901

Authors: MATSUKURA N ONDA M TOKUNAGA A KATO S YOSHIYUKI T HASEGAWA H YAMASHITA K TOMTITCHONG P HAYASHI A
Citation: N. Matsukura et al., ROLE OF HELICOBACTER-PYLORI INFECTION IN PERFORATION OF PEPTIC-ULCER - AN AGE-MATCHED AND GENDER-MATCHED CASE-CONTROL STUDY, Journal of clinical gastroenterology, 25, 1997, pp. 235-239

Authors: ATSUNORI F KAZUHIRO C MIKI M MASAYOSHI M YOSHIYUKI T
Citation: F. Atsunori et al., EFFECTS OF SEVERAL HORMONES ON EXPRESSION OF VACUOLAR H-PYROPHOSPHATASE AND H+-ATPASE FROM BARLEY ROOTS(), Plant physiology, 114(3), 1997, pp. 978-978

Authors: MATSUKURA N ONDA M OKAWA K KATO S HASEGAWA H YOSHIYUKI T TOKUNAGA A YAMAHATSU J YAMADA N
Citation: N. Matsukura et al., 2-STEP THERAPY FOR HELICOBACTER-PYLORI ERADICATION WITH LANSOPRAZOLE,AMOXICILLIN AND A MUCOSAL PROTECTIVE AGENT - ECABET SODIUM, Gastroenterology, 112(4), 1997, pp. 214-214

Authors: MIYASHITA M ONDA M OKAWA K MATSUTANI T YOSHIYUKI T SASAJIMA K KYONO S YAMASHITA K
Citation: M. Miyashita et al., ENDOSCOPIC DEXAMETHASONE INJECTION FOLLOWING BALLOON DILATATION OF ANASTOMOTIC STRICTURE AFTER ESOPHAGOGASTROSTOMY, The American journal of surgery, 174(4), 1997, pp. 442-444

Authors: MATSUKURA N ONDA M SHIRAKAWA T TAKITA M AKIYA Y OHKAWA K YOSHIYUKI T HASEGAWA H KATO S TOKUNAGA A YAMAHATSU J YAMASHITA K
Citation: N. Matsukura et al., HIGH ERADICATION RATE OF HELICOBACTER-PYLORI WITH LANSOPRAZOLE PLUS AMOXICILLIN PLUS ECABET SODIUM - NEW TRIPLE THERAPY WITH NOVEL MUCOSAL PROTECTIVE AGENT FOR THE TREATMENT OF PEPTIC-ULCER, Gastroenterology, 110(4), 1996, pp. 190-190

Authors: TOKUNAGA A ONDA M OKUDA T TERAMOTO T FUJITA I MIZUTANI T KIYAMA T YOSHIYUKI T NISHI K MATSUKURA N
Citation: A. Tokunaga et al., CLINICAL-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR (EGF), EGF RECEPTOR,AND C-ERBB-2 IN HUMAN GASTRIC-CANCER, Cancer, 75(6), 1995, pp. 1418-1425
Risultati: 1-8 |